Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.640
-0.090 (-3.30%)
Oct 30, 2025, 4:00 PM EDT - Market closed
Perspective Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts that cover Perspective Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $12.3, which forecasts a 365.91% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $16.
Price Target: $12.3 (+365.91%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Perspective Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 5 | 6 | 6 | 6 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +430.30% | Oct 13, 2025 |
| BTIG | BTIG | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +430.30% | Oct 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +278.79% | Oct 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +278.79% | Sep 19, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $9 → $12 | Strong Buy | Maintains | $9 → $12 | +354.55% | Jun 23, 2025 |
Financial Forecast
Revenue This Year
1.13M
from 1.45M
Decreased by -22.08%
Revenue Next Year
775.31K
from 1.13M
Decreased by -31.57%
EPS This Year
-1.21
from -1.23
EPS Next Year
-1.38
from -1.21
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.6M | 1.7M | |||
| Avg | 1.1M | 775,312 | |||
| Low | 619,360 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.5% | 48.3% | |||
| Avg | -22.1% | -31.6% | |||
| Low | -57.4% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.06 | -0.87 | |||
| Avg | -1.21 | -1.38 | |||
| Low | -1.31 | -1.94 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.